Pregnancy Prevention
📧 Sign up to get email alerts when something new happens for Pregnancy Prevention.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Phase II Study of Ovulation in Obese Women [Phase 2]
Phase II study evaluating ovulation modulation in obese women for pregnancy prevention; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days [Phase 2]
Phase 2 trial evaluating oral levonorgestrel plus meloxicam (IG-002) showing delays ovulation by seven days in normal menstruating women.
-
FDA approval · 2025-10-01FDA Approved: MIUDELLA — Supplemental Application (Sebela Women's Health Inc.)
FDA approved a supplemental application for MIUDELLA (copper intrauterine device) from Sebela Women's Health Inc. This action updates the pr…
-
FDA approval · 2025-09-30FDA Approved: LEVONORGESTREL — Original Application (Camber Consumer Care Inc)
FDA approved Camber Consumer Care Inc's original application for levonorgestrel, a generic oral contraceptive.
-
FDA approval · 2025-05-02FDA Approved: AVERI — Original Application (Avion Pharmaceuticals, LLC)
FDA approved AVERI, a desogestrel and ethinyl estradiol combination oral contraceptive, developed by Avion Pharmaceuticals under an Original…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Healthy Adolescent Transitions (HAT) [Phase 2]
Phase 2 clinical trial update for Healthy Adolescent Transitions (HAT) completed, focusing on pregnancy prevention and life skill developmen…
-
FDA approval · 2023-09-25FDA Approved: JUNEL FE 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for JUNEL FE 28 DAY, a norethindrone acetate/ethinyl estradiol/ferrous fumarate oral contraceptive.
-
FDA approval · 2023-08-16FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' generic drospirenone/ethinyl estradiol, making this combined oral contra…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females [Phase 2]
Phase 2 trial evaluating a contraceptive vaginal ring (LSP-5415) on ovarian function in healthy adult females has completed.
-
FDA label_change · 2023-02-03FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)
FDA approved a supplemental application for CHATEAL EQ (levonorgestrel and ethinyl estradiol) submitted by Afaxys Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study [Phase 2]
Phase 2 open-label randomized crossover pharmacokinetics study completed.
-
FDA approval · 2022-04-29FDA Approved: LUTERA — Supplemental Application (Mayne Pharma Inc.)
FDA approved a supplemental application for LUTERA (levonorgestrel and ethinyl estradiol) filed by Mayne Pharma Inc.
-
FDA label_change · 2022-04-29FDA Approved: TRI-SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for TRI-SPRINTEC (norgestimate and ethinyl estradiol) submitted by Teva Pharmaceuticals USA, Inc., r…
-
FDA approval · 2022-04-29FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the norethindrone/ethinyl estradiol/ferrous fumarate oral contraceptive manufactured by Mylan Ph…
-
FDA approval · 2022-04-29FDA Approved: TWIRLA — Supplemental Application (Agile Therapeutics, Inc.)
The FDA approved a supplemental application for TWIRLA (levonorgestrel/ethinyl estradiol) from Agile Therapeutics, Inc., indicating approval…
-
FDA approval · 2020-07-17FDA Approved: DROSPIRENONE AND ETHINYL ESTRADIOL — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's supplemental application for a generic drospirenone/ethinyl estradiol product (oral contraceptive).
-
FDA approval · 2020-04-30FDA Approved: VESTURA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for VESTURA, a generic combination oral contraceptive containing drospirenone and ethinyl estra…
-
FDA approval · 2019-12-23FDA Approved: DEPO-SUBQ PROVERA — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for DEPO-SUBQ PROVERA (medroxyprogesterone acetate) from Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Puerto Rico Cuidalos Parent-adolescent Program [NA]
Clinical trial update for the Puerto Rico Cuidalos Parent-adolescent Program completed with results posted in 2019.
-
FDA approval · 2017-08-09FDA Approved: LEVONEST — Supplemental Application (Northstar Rx LLC)
FDA approves a supplemental application for LEVONEST (levonorgestrel and ethinyl estradiol) from Northstar Rx LLC.
-
FDA approval · 2017-08-09FDA Approved: AMETHYST — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for AMETHYST (levonorgestrel and ethinyl estradiol) submitted by Teva Pharmaceuticals, Inc. The supp…
-
FDA approval · 2017-08-09FDA Approved: ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Ethynodiol Diacetate and Ethinyl Estradiol from Mylan Pharmaceuticals Inc., a combined oral …
-
FDA approval · 2017-02-02FDA Approved: NEXESTA FE — Original Application (Aurobindo Pharma Limited)
FDA approved NEXESTA FE, a generic fixed-dose combination oral contraceptive containing norethindrone, ethinyl estradiol, and ferrous fumara…
-
FDA approval · 2015-06-12FDA Approved: LEVONORGESTREL AND ETHINYL ESTRADIOL — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's levonorgestrel and ethinyl estradiol combination via an Original Application, establishing a new approved oral c…
-
FDA approval · 2015-04-01FDA Approved: ENSKYCE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for ENSKYCE (desogestrel and ethinyl estradiol), resulting in an approved chang…